Assignee
ADURO BIOTECH HOLDINGS EUROPE B V
NL·12 granted patents·5 pending applications·63 citations·filing 2012–2024
Top patents by PatentIndex Score
17 records- 0193US10961316B2Humanized antibodies which bind to human APRIL (“a proliferation-inducing ligand”)ADURO BIOTECH HOLDINGS EUROPE B V·Filed 2019·Granted Mar 30, 2021·4 cites·5 claims
- 0292US10377830B2Method of treating IgA nephropathy by administering humanized APRIL-binding antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2018·Granted Aug 13, 2019·13 cites·5 claims
- 0392US9969808B2Altered APRIL binding antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2016·Granted May 15, 2018·13 cites·26 claims
- 0491US10851164B2Anti-SIRPα antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2018·Granted Dec 1, 2020·9 cites·19 claims
- 0589US10107821B2Proliferation-inducing ligand (APRIL)-binding peptidesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2014·Granted Oct 23, 2018·8 cites·3 claims
- 0688US2025101121A1Method of treating iga nephropathy by administering altered antibodies which bind human a proliferation-inducing ligand (april) proteinADURO BIOTECH HOLDINGS EUROPE B V·Filed 2024·Application pending·0 cites
- 0786US9527916B2Agonistic antibody to CD27ADURO BIOTECH HOLDINGS EUROPE B V·Filed 2012·Granted Dec 27, 2016·14 cites·19 claims
- 0883US11047864B2Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a human sampleADURO BIOTECH HOLDINGS EUROPE B V·Filed 2018·Granted Jun 29, 2021·2 cites·6 claims
- 0983US2024353422A1Method for obtaining april-binding peptides, process for producing the peptides, april-binding peptides obtainable with said method/process and use of the april-binding peptidesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2024·Application pending·0 cites
- 1081US2025179206A1Combining cd27 agonists and immune checkpoint inhibition for immune stimulationADURO BIOTECH HOLDINGS EUROPE B V·Filed 2024·Application pending·0 cites
- 1174US11959924B2Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a sampleADURO BIOTECH HOLDINGS EUROPE B V·Filed 2021·Granted Apr 16, 2024·0 cites·23 claims
- 1273US12145992B2Method of treating IgA nephropathy by administering altered antibodies which bind human a proliferation-inducing ligand (APRIL) proteinADURO BIOTECH HOLDINGS EUROPE B V·Filed 2021·Granted Nov 19, 2024·0 cites·12 claims
- 1366US12168693B2Combining CD27 agonists and immune checkpoint inhibition for immune stimulationADURO BIOTECH HOLDINGS EUROPE B V·Filed 2019·Granted Dec 17, 2024·0 cites·5 claims
- 1465US2022135671A1Anti-sirp alpha antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2020·Application pending·0 cites
- 1548US2017267771A1Agonistic antibody to cd27ADURO BIOTECH HOLDINGS EUROPE B V·Filed 2016·Application pending·0 cites
- 1642US10808030B2Anti-HCTLA-4 antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2017·Granted Oct 20, 2020·0 cites·10 claims
- 1734US10494436B2Anti-PD-1 antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2017·Granted Dec 3, 2019·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when ADURO BIOTECH HOLDINGS EUROPE B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →